メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
Keio University ホーム
ヘルプ＆FAQ
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
松元 美奈子
衛生学公衆衛生学
ウェブサイト
https://k-ris.keio.ac.jp/html/100002123_ja.html
h-index
175
被引用数
6
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2017
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(19)
類似のプロファイル
(6)
フィンガープリント
Minako Matsumotoが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Dyslipidemia
82%
Atherosclerosis
65%
Glutamic Acid
44%
Coronavirinae
41%
Glucosaminidase
41%
Sarcopenia
41%
Disease
41%
Acetic Acid Derivative
41%
Hospital Infection
41%
Environmental Exposure
41%
Coronary Artery Disease
41%
Nonalcoholic Fatty Liver
41%
Health Hazard
34%
Diabetes Mellitus
34%
Metformin Plus Pioglitazone
31%
Alanine
24%
Isoleucine
24%
Creatinine
20%
Morbidity
20%
Ethanol
20%
Low Density Lipoprotein Cholesterol
20%
Uric Acid
20%
Uncoupling Protein 2
20%
Glycosylated Hemoglobin
20%
Biological Marker
20%
Cardiovascular Disease
20%
Dysosmia
16%
Amlodipine Plus Telmisartan
15%
Diseases
13%
Comorbidity
13%
Cigarette Smoking
13%
Cigarette Smoke
10%
Antihypertensive Agent
10%
Epidemiology
10%
Bevantolol
10%
Hydrochlorothiazide Plus Valsartan
10%
Quinapril
10%
Amosulalol
10%
Bufetolol
10%
Gamma Oryzanol
10%
Temocapril
10%
Buformin
10%
Arotinolol
10%
Bromide
10%
Lomitapide
10%
Saxagliptin
10%
Infection
8%
Secondary Infection
8%
Aromatic Amino Acid
6%
Medicine and Dentistry
Cohort Analysis
92%
Drug Therapy
82%
Metabolomics
47%
Smoking
41%
Odds Ratio
41%
Smoking Habit
41%
Diabetes
41%
Forced Expiratory Volume
41%
Dyslipidemia
41%
Arterial Stiffness
41%
Atherosclerosis
41%
Sarcopenia
41%
Counseling
41%
Community-Dwelling Older Adults
41%
Coronary Artery
41%
Mendelian Randomization Analysis
41%
Insulin Resistance
41%
Body Mass Index
41%
Disease
33%
Coronary Artery Disease
27%
Tamsulosin
24%
Risk Stratification
22%
Logistic Regression Analysis
21%
Contact Examination
16%
Dysosmia
16%
Muscle Strength
13%
Morbidity
13%
Analysis of Variance
13%
Sleep Quality
13%
Physical Performance
13%
Homeostatic Model Assessment
13%
Sleep Time
9%
Maturity Onset Diabetes of the Young
9%
Virus Shedding
8%
Transmission-Based Precautions
8%
Cancer Mortality
8%
Health Status
8%
Molecular Profiling
8%
Cardiovascular Disease
8%
Aging-Associated Diseases
8%
Pathophysiology
8%
Metabolome
8%
Women's Health
8%
Social Determinants of Health
8%
Cancer Incidence
8%
Biological Marker
8%
Sequela
8%
Sensitivity and Specificity
6%
Smoke
5%
Prevalence
5%
Keyphrases
Sars-cov-2 Infection
41%
Site Practice
41%
Medication Counseling
41%
Preclinical Training
41%
Counseling Practices
41%
Junior Students
41%
Non-alcoholic Fatty Liver Disease (NAFLD)
41%
Metabolic Profiling
41%
Community-dwelling
41%
Japanese Community
41%
Arterial Stiffness
41%
Metabolomics
41%
Genome-wide Association Study
41%
Multivariable Mendelian Randomization
41%
Amino Acids
41%
Mendelian Randomization
41%
Plasma Amino Acids
41%
Cardiometabolic Disease
41%
Dual Users
25%
Small Group Discussion
24%
Japan
24%
Cardio-ankle Vascular Index
24%
Metformin Hydrochloride
18%
Contact Tracing
16%
Large-scale Isolation
16%
Advanced Medication
16%
Precision Prevention
16%
Aging
16%
Yamagata Prefecture
16%
Glutamate Pathway
15%
Potential Biomarkers
15%
Long Sleeper
13%
Correlation Changes
13%
Mitiglinide Calcium
13%
Mendelian Randomization Analysis
13%
Amino Acid Content
13%
Systolic Blood Pressure
13%
Causal Effect
13%
Dysosmia
11%
Urinary N-acetyl-β-D-glucosaminidase
11%
Pathway Network
11%
Metabolic Dyslipidemia
11%
Tobacco Products
10%
Smoking Tobacco
10%
Bevantolol
9%
Ipragliflozin L-proline
9%
Saxagliptin
9%
Lomitapide
9%
Arotinolol
9%
Buformin
9%
